Research programme: glucokinase activators - vTv Therapeutics
Latest Information Update: 19 May 2020
At a glance
- Originator TransTech Pharma
- Developer vTv Therapeutics LLC
- Class Small molecules
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 18 May 2020 Allergan has been acquired and merged into AbbVie
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA (PO)
- 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc